Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News MeRT FDA clearance gives Wave Neuroscience a first-mover role in biomarker-guided PTSD care Find out how Wave Neuroscience’s MeRT FDA clearance could reshape biomarker-guided neuromodulation for PTSD care. byPallavi MadhirajuJune 12, 2026